The AHA released a scientific statement on tailored exercise training for patients with high-risk cardiovascular conditions.
The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.
Kalshi and AppliedXL launch a pilot prediction market for late-stage clinical trial outcomes and FDA decisions using objective public data sources.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results